501 filings
Page 18 of 26
EFFECT
AADI
Aadi Bioscience Inc
18 Sep 18
Notice of effectiveness
12:00am
CORRESP
AADI
Aadi Bioscience Inc
14 Sep 18
Correspondence with SEC
12:00am
UPLOAD
AADI
Aadi Bioscience Inc
11 Sep 18
Letter from SEC
12:00am
POS AM
AADI
Aadi Bioscience Inc
31 Aug 18
Prospectus update (post-effective amendment)
12:00am
4
AADI
Aadi Bioscience Inc
22 Aug 18
Aerpio Pharmaceuticals / AG NOVARTIS ownership change
12:00am
10-Q
2018 Q2
AADI
Aadi Bioscience Inc
Quarterly report
14 Aug 18
12:52pm
8-K
AADI
Aadi Bioscience Inc
14 Aug 18
Aerpio Reports Second Quarter 2018 Financial Results and Provides Business Update
7:23am
CT ORDER
AADI
Aadi Bioscience Inc
24 Jul 18
Confidential treatment order
12:00am
SC 13D/A
Novartis Bioventures Ltd
9 Jul 18
Aerpio Pharmaceuticals, Inc.
4:01pm
SC 13D/A
AADI
Aadi Bioscience Inc
3 Jul 18
Aerpio Pharmaceuticals, Inc.
5:03pm
4
AADI
Aadi Bioscience Inc
2 Jul 18
Change in insider ownership
4:56pm
4
Chau Quang Khuong
2 Jul 18
Aerpio Pharmaceuticals / Chau Quang Khuong ownership change
4:51pm
SC 13D/A
Orbimed Advisors LLC
2 Jul 18
Beneficial ownership report (amended)
4:44pm
4
AADI
Aadi Bioscience Inc
29 Jun 18
Aerpio Pharmaceuticals / Muneer A Satter ownership change
4:17pm
8-K
AADI
Aadi Bioscience Inc
27 Jun 18
Aerpio Pharmaceuticals Announces Proposed Public Offering of Common Stock and Uplisting to Nasdaq Capital Market
4:56pm
424B5
AADI
Aadi Bioscience Inc
26 Jun 18
Prospectus supplement for primary offering
9:30am
CERT
AADI
Aadi Bioscience Inc
25 Jun 18
Certification of approval for exchange listing
5:25pm
8-A12B
AADI
Aadi Bioscience Inc
25 Jun 18
Registration of securities on exchange
5:10pm
424B5
AADI
Aadi Bioscience Inc
25 Jun 18
Prospectus supplement for primary offering
5:08pm
424B3
AADI
Aadi Bioscience Inc
25 Jun 18
Prospectus supplement
8:33am